Clinical outcomes of two infants with cystic fibrosis, including presence of the vas deferens, born to a woman with cystic fibrosis taking CFTR modulators during both pregnancies

MeSH terms

• Adult
• Aminophenols / therapeutic use
• Chloride Channel Agonists / therapeutic use
• Cystic Fibrosis Transmembrane Conductance Regulator* / genetics
• Cystic Fibrosis* / complications
• Cystic Fibrosis* / drug therapy
• Female
• Humans
• Infant, Newborn
• Male
• Pregnancy
• Pregnancy Complications / drug therapy
• Quinolones / therapeutic use
• Vas Deferens*